Table 1 Descriptive statistics and bivariate analysis of patients’ characteristics and polypharmacy
Characteristic | No Polypharmacy (< 5) | Polypharmacy ( > = 5) | P-Value | Total |
|---|---|---|---|---|
N | 156 (31.5%) | 340 (68.5%) | Â | 496 |
Age a | 78.2 | 78.8 | 0.942 | 78.6 |
Gender b | Â | Â | Â | Â |
 Male | 68 (34.9%) | 127 (65.1%) | 0.187 | 301 (60.7%) |
 Female | 88 (29.2%) | 213 (70.8%) | 195 (39.3%) | |
Smoker (490) b | Â | Â | Â | Â |
 Non-smoker | 131 (30.9%) | 293 (69.1%) | 0.257 | 424 (86.5%) |
 Smoker | 25 (37.9%) | 41 (62.1%) |  | 66 (13.5%) |
ASCVD Score b (249) | Â | Â | Â | Â |
 Low-intermediate risk | 25 (40.3%) | 37 (59.7%) | 0.093 | 62 (24.9%) |
 High risk | 54 (28.9%) | 133 (71.1%) |  | 187 (75.1%) |
Charlson Comorbidity Index (18) b | Â | Â | Â | Â |
 Mild-Moderate | 50 (44.2%) | 63 (55.8%) | 0.001* | 113 (22.8%) |
 Severe | 106 (27.7%) | 277 (72.3%) |  | 383 (77.2%) |
Dementia b | Â | Â | Â | Â |
 Yes | 38 (30.6%) | 86 (69.4%) | 0.823 | 124 (25%) |
 No | 118 (31.7%) | 254 (68.3%) |  | 372 (75%) |